Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

Peculiarities of drug therapy in pediatrics: help of a nurse in organizing medical care for children

DOI: https://doi.org/ 10.29296/25879979-2022-01-01
Download full text PDF
Issue: 
1
Year: 
2022

K.I. Grigorуev(1), L.A. Kharitonova(1), O.F. Vykhristyuk(1-2), L.F. Nemtyreva(3), Z.A. Rakhmatullina(2) 1-Pirogov’s Russian state national research university of the Ministry of health of the Russian Federation 2-Peoples’ Friendship University Medical Institute of Russia 3-Sechenov’s First Moscow state medical University of the Ministry of health of the Russian Federation

The use of drugs in pediatrics has a number of features and is associated with a number of applied problems. Medical workers are often faced with the prescription of drugs «off-label», lack of drugs in appropriate doses for children and, accordingly, with the need to develop appropriate dosage forms. The article discusses the issues of the safety of the use of drugs in children and the principles of drug provision in pediatrics. The issues of drug provision in pediatrics are considered. It was shown that the largest number of children’s dosage forms was registered in the group of drugs acting on the central nervous system, mainly in the subgroup of analgesics. In the groups of drugs that act on the cardiovascular system, regulate metabolic processes, for the treatment of infectious diseases, children’s dosage forms are presented in an extremely limited number, and in the groups of drugs for the treatment of malignant neoplasms and diagnostic drugs, there are simply no special pediatric dosage forms. The topic is a continuation of an article published in the journal «Medizinskaya Sestra» /Nurse (Rus) in 2020 (Grigoriev K.I. and Vykhristyuk O.F, «Medicines and children. Problems of the XXI century»: vol. 22, №1: 5-14)
Keywords: 
pediatrics
organization of pharmacotherapy
children’s dosage forms
nurse

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Knyazkova I.I. Features of pharmacodynamics of drugs in children: the importance of pharmacogenomics and pharmacogenetics. Pediatrics. 2016; 37. № 2: 42-44.
  2. Namazova-Baranova L.S., Zelenkova I.V., Gubanova S.G., Pashkov A.V., Naumova I.V., Efendieva K.E., Gankovsky V.A. Irrational pharmacotherapy as one of the causes of medical errors. Pediatricheskaya farmakologiya (Pediatric pharmacology). 2021; 18(1):31–37. doi: 10.15690/pf. v18i1.2234
  3. Kotelnikov G.P., Shpigel A.S. The system of introduction and implementation of the principles of evidence-based medicine is a necessary and obligatory component of improving the quality of education in the context of healthcare modernization. Meditsinskoye obrazovaniye i professional’noye razvitiye (Medical education and professional development). 2012; №1(7): 43-46.
  4. Burbello A.T., Fedorenko A.S., Sychev D.A., et al. The value of a professional standard in the work of a clinical pharmacologist in a medical organization. Bulletin of the North-Western State Medical University. I.I. Mechnikov. 2018; vol. 10. № 3: 5–18. doi: 10.17816/mechnikov20181035-18
  5. Shestakov V.N., Polyakov S.V., Persanova L.V., Andreevicheva T.Yu., Veretennikova M.A., Ulyanov A.M., Skupchenko V.V., Lobov A.V. Mamedova D.A., Miranyan K.A., Jafarova T.A. Medicines in pediatrics: problems and perspectives. Ratsional’naya farmakoterapiya. Terapevt (Rational pharmacotherapy. Therapist). 2019; № 11: 57-61.
  6. Solopova A., Vlasina A., Nlkulenkova Yu. Current approaches to rehabilitating children with gynecological cancer Vrach 2019. (30) № 9. С. 3-10
  7. Baranov A., Namazova L., Saitkulov K., Smitienko I. Russian national pediatric formulary and rational use of medicines: modern approaches to patient education. Pediatricheskaya farmakologiya (Pediatric pharmacology). 2006; 3(6): 6-9.
  8. Titova A.R., Asetskaya I.L., Polivanov V.A., Zyryanov S.K. Russian study of off-label drug prescriptions in pediatric practice: 2015 vs 2012. Kachestvennaya klinicheskaya praktika (Quality clinical practice). 2016; № 4: 54–62.
  9. Zyryanov S.K., Sokolov A.V., Belousov Yu.B. Pharmacokinetics of drugs in children of different age groups. Meditsinskiye tekhnologii. Otsenka i vybor (Medical technologies. Evaluation and choice). 2011; № 2: 70–76.
  10. Clavenna A., Bonati M. Adverse drug reactions in childhood: a review of prospective studies and safety alerts. Arch DisChild. 2009; V.94: 724–728.
  11. Narkevich I.A., Nemyatykh O.D., Basakina I.I. Pharmaceutical development of drugs for pediatric practice: fundamentals and specific features. Razrabotka i registratsiya lekarstvennykh sredstv (Development and registration of medicines). 2016; № 3: 194–201.
  12. Belyatskaya A. V., Krasnyuk I. I., Krasnyuk I. I. (Jr.), Stepanova O. I., Korol L. A., Rostopchina O. V. The use of finished drugs in the extemporaneous manufacture of powders. Razrabotka i registratsiya lekarstvennykh sredstv (Development and registration of medicines). 2017; № 1: 82–85.
  13. Polyaev Yu.A., Postnikov S.S., Mylnikov A.A., Narbutov A.G. Place of propranolol in the treatment of infantile hemangiomas. Detskaya bol’nitsa (Children Hospital). 2012; № 4: 46-49.
  14. Kondyurina E.G., Zelenskaya V.V. Therapy of acute respiratory infections in children from the standpoint of evidence-based medicine. Voprosy sovremennoy pediatrii (Questions of modern pediatrics). 2016; 15(6): 568–575. doi:10.15690/vsp. v15i6.1653
  15. Gudima G.O., Khaitov R.M., Kudlay D.A., Khaitov M.R. Molecular and immunological aspects of the diagnosis, prevention and treatment of coronavirus infection. Immunology. 2021; 42(3): 198–210. DOI: https://doi.org/10.33029/0206-4952-2021-42-3-198-210
  16. Drogovoz S.M., Butko Ya.A., Ivantsik L.B., Shchekina E.G., Belik G.V., Lukyanchuk V.D. Features of the use of off-label drugs in pediatrics. Zaporozhskiy meditsinskiy zhurnal (Zaporozhye Medical Journal). 2020; v. 22, № 5(122): 714-718.
  17. Tulupov D.A., Fedotov F.A., Karpova E.P., Grabovskaya V.A. Modern aspects of the use of nasal vasoconstrictor and auxiliary drugs in pediatric practice. Meditsinskiy sovet (Medical advice). 2018; № 2: 114–117.
  18. Shilov V.V., Derevianko E.S., Al-Madkhun A.I. Modern ideas about acute Naphazoline poisoning in children / Preventive medicine: a collection of conference proceedings. St. Petersburg: North-Western State Medical Institute. university. I.I. Mechnikova, 2019; ch. 2: 208–215.
  19. Gromova O.A. Vitamin D is a paradigm shift. M.: GEOTAR-Media, 2021. 2nd edition – 736 p.
  20. Avdeeva Zh.I., Soldatov A.A., Bondarev V.P., Merkulov V.A. Preparations of monoclonal antibodies in autoimmune diseases (safety issues). Voprosy gematologii/onkologii i immunopatologii v pediatrii (Issues of hematology/oncology and immunopathology in pediatrics). 2020; 19(4): 96-100.
  21. Filippova A.V., Kolbin A.S., Verbitskaya E.V., Glagolev S.V., Polivanov V.A. Systemic characteristics of the safety profile of drugs of monoclonal antibodies used in rheumatological practice. Kachestvennaya klinicheskaya praktika (Quality clinical practice). 2019; (2): 75-84. doi.org/10.24411/2588-0519-2019-10075
  22. Aslanyants S. K., Adzhienko V. L., Kulik V. V. Analysis of the structure of the nomenclature of children’s drugs registered in the Russian Federation. Bulletin of the Volgograd State Medical University. 2016; № 1 (57); 22–24.
  23. Martsevich S.Yu., Navasardyan A.R., Komkova N.A. The prescription of medicines is not in accordance with the official instructions for medical use (off-label). Possible causes, types and consequences. Legal regulation in the Russian Federation. Ratsional’naya farmakoterapiya v kardiologii (Rational pharmacotherapy in cardiology). 2017; vol. 13. № 5: 667–674. doi: 10.20996/1819-6446-2017-13-5-667-674
  24. Egorova S.N., Kondakov S.E., Gordeev V.V., Beletskii S.O., Khayatov A.R., Ikhalainen E.S. Modern problems of drug dosing for children in the Russian Federation. Bulletin of the Smolensk State Medical Academy 2019; vol. 18, № 4: 220-224.
  25. Ivanovska V., Rademaker C.M., van Dijk L., Mantel-Teeuwisse A.K. Pediatric drug formulation: a review of challenges and progress. Pediatrics. 2014; 134(2): 361-372. doi: 10.1542/peds.2013-3225.
  26. Batchelor H. K., Marriott J. F. Formulations for children: problems and solutions. British journal of clinical pharmacology. 2015; T. 79. № 3: 405–418.